{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:51:24Z","timestamp":1784289084159,"version":"3.55.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,3,27]]},"DOI":"10.18632\/oncotarget.24740","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T12:46:48Z","timestamp":1522068408000},"page":"16489-16500","source":"Crossref","is-referenced-by-count":11,"title":["Targeting oncogenic Ras by the <i>Clostridium perfringens<\/i> toxin TpeL"],"prefix":"10.18632","volume":"9","author":[{"given":"Bj\u00f6rn","family":"Schorch","sequence":"first","affiliation":[{"name":"Institut f\u00fcr Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Heni","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour-Imene","family":"Zahaf","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Brummer","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Molekulare Medizin und Zellforschung, Medizinische Fakult\u00e4t, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"},{"name":"German Cancer Consortium (DKTK), Partner Site Freiburg, Germany, and German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Centre for Biological Signalling Studies (BIOSS), Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mione","sequence":"additional","affiliation":[{"name":"Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Eggestein-Leopoldshafen, Germany"},{"name":"Present Address: Center for Integrative Biology, University of Trento, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudula","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Papatheodorou","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"},{"name":"Present Address: Institute of Pharmaceutical Biotechnology, University of Ulm, Ulm, Germany"},{"name":"Present Address: Institute of Pharmacology and Toxicology, University of Ulm Medical Center, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Aktories","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakult\u00e4t, Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"},{"name":"Centre for Biological Signalling Studies (BIOSS), Albert-Ludwigs-Universit\u00e4t Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrm1105","article-title":"Ras proteins: different signals from different locations","volume":"4","author":"Hancock","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/366643a0","article-title":"Proteins regulating Ras and its relatives","volume":"366","author":"McCormick","year":"1993","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Barbacid","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"4","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1126\/science.1062023","article-title":"The guanine nucleotide-binding switch in three dimensions","volume":"294","author":"Wittinghofer","year":"2001","journal-title":"Science"},{"key":"5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2362.1990.tb01848.x","article-title":"oncogenes: their role in neoplasia","volume":"20","author":"Barbacid","year":"1990","journal-title":"Eur J Clin Invest"},{"key":"6","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Mattos","year":"2012","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd.2016.139","article-title":"Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design","volume":"15","author":"Shokat","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"8","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1099\/mic.0.2006\/002287-0","article-title":"A novel toxin homologous to large clostridial cytotoxins found in culture supernatant of Clostridium perfringens type C","volume":"153","author":"Shimizu","year":"2007","journal-title":"Microbiology"},{"key":"9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/IAI.01019-10","article-title":"Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins","volume":"79","author":"Sakurai","year":"2011","journal-title":"Infect Immun"},{"key":"10","doi-asserted-by":"crossref","first-page":"24929","DOI":"10.1074\/jbc.M112.347773","article-title":"Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells","volume":"287","author":"Aktories","year":"2012","journal-title":"J Biol Chem"},{"key":"11","doi-asserted-by":"crossref","first-page":"15R","DOI":"10.1093\/glycob\/cwm004","article-title":"Rho-glucosylating Clostridium difficile toxins A and B: New insights into structure and function","volume":"17","author":"Aktories","year":"2007","journal-title":"Glycobiology"},{"key":"12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbagen.2004.03.014","article-title":"Large clostridial cytotoxins: cellular biology of Rho\/Ras-glucosylating toxins","volume":"1673","author":"Aktories","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.biocel.2007.12.014","article-title":"Clostridium difficile toxins: more than mere inhibitors of Rho proteins","volume":"40","author":"Just","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","article-title":"Clostridium difficile toxins: mechanism of action and role in disease","volume":"18","author":"Ballard","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"15","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1073\/pnas.1323790111","article-title":"LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins","volume":"111","author":"Aktories","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.febslet.2009.09.006","article-title":"Distinct kinetics of (H\/K\/N)Ras glucosylation and Rac1 glucosylation catalysed by Clostridium sordellii lethal toxin","volume":"583","author":"Genth","year":"2009","journal-title":"FEBS Lett"},{"key":"17","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Tsang","year":"2010","journal-title":"Nature"},{"key":"18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","article-title":"Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF","volume":"140","author":"Marais","year":"2010","journal-title":"Cell"},{"key":"19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Rosen","year":"2010","journal-title":"Nature"},{"key":"20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm3979","article-title":"Regulation of RAF protein kinases in ERK signalling","volume":"16","author":"Therrien","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/onc.2010.408","article-title":"Hyperactivation of MEK-ERK1\/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells","volume":"30","author":"Aplin","year":"2011","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/emboj.2012.100","article-title":"Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling","volume":"31","author":"Brummer","year":"2012","journal-title":"EMBO J"},{"key":"23","doi-asserted-by":"crossref","first-page":"e15170","DOI":"10.1371\/journal.pone.0015170","article-title":"Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish","volume":"5","author":"Mione","year":"2010","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1158\/0008-5472.CAN-04-1911","article-title":"Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells","volume":"65","author":"Dhillon","year":"2005","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jcp.21753","article-title":"Role of RAF\/MEK\/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines","volume":"220","author":"Zoli","year":"2009","journal-title":"J Cell Physiol"},{"key":"26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000086537","article-title":"Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer","volume":"5","author":"Pilarsky","year":"2005","journal-title":"Pancreatology"},{"key":"27","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.biocel.2013.09.016","article-title":"CD46: the \u2018multitasker\u2019 of complement proteins","volume":"45","author":"Kemper","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2249.2011.04400.x","article-title":"CD46 in innate and adaptive immunity: an update","volume":"164","author":"Kemper","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"29","doi-asserted-by":"crossref","first-page":"12785","DOI":"10.1128\/JVI.01732-07","article-title":"Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob","volume":"81","author":"Lieber","year":"2007","journal-title":"J Virol"},{"key":"30","doi-asserted-by":"crossref","first-page":"38060","DOI":"10.1038\/srep38060","article-title":"Tumor-specific delivery of biologics by a novel T-cell line HOZOT","volume":"6","author":"Kagawa","year":"2016","journal-title":"Sci Rep"},{"key":"31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Gardiner","year":"2012","journal-title":"Nature"},{"key":"32","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Lin","year":"2008","journal-title":"Science"},{"key":"33","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1101\/gad.1415606","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"20","author":"Depinho","year":"2006","journal-title":"Genes Dev"},{"key":"34","doi-asserted-by":"crossref","first-page":"16134","DOI":"10.1074\/jbc.273.26.16134","article-title":"Functional consequences of monoglucosylation of H-Ras at effector domain amino acid threonine-35","volume":"273","author":"Just","year":"1998","journal-title":"J Biol Chem"},{"key":"35","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1152\/physrev.00033.2007","article-title":"LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies","volume":"88","author":"Strickland","year":"2008","journal-title":"Physiol Rev"},{"key":"36","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/toxins5081486","article-title":"Immunotoxins: the role of the toxin","volume":"5","author":"Fitzgerald","year":"2013","journal-title":"Toxins (Basel)"},{"key":"37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijmm.2008.08.003","article-title":"Pseudomonas exotoxin A: from virulence factor to anti-cancer agent","volume":"299","author":"Elsasser-Beile","year":"2009","journal-title":"Int J Med Microbiol"},{"key":"38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01803778","article-title":"Recombinant immunotoxins","volume":"38","author":"FitzGerald","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2008.06.017","article-title":"Targeted therapy of cancer using diphtheria toxin-derived immunotoxins","volume":"13","author":"Verma","year":"2008","journal-title":"Drug Discov Today"},{"key":"40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200923010-00001","article-title":"Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies","volume":"23","author":"Kreitman","year":"2009","journal-title":"BioDrugs"},{"key":"41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.1999.5614","article-title":"Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue","volume":"76","author":"Kaul","year":"2000","journal-title":"Gynecol Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00005-011-0146-x","article-title":"Complement in cancer and cancer immunotherapy","volume":"59","author":"Donev","year":"2011","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"43","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ejca.2014.05.005","article-title":"The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack","volume":"50","author":"Wollenberg","year":"2014","journal-title":"Eur J Cancer"},{"key":"44","first-page":"2985","article-title":"Fiber-substituted conditionally replicating adenovirus for oncolysis of human renal carcinoma cells","volume":"32","author":"Gotoh","year":"2012","journal-title":"Anticancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.32607\/20758251-2011-3-3-100-106","article-title":"An Efficient Method for the Delivery of the Interleukin-2 Gene to Human Hematopoietic Cells using the Fiber-Modified Recombinant Adenovirus","volume":"3","author":"Gintsburg","year":"2011","journal-title":"Acta Naturae"},{"key":"46","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01308-08","article-title":"andproperties of adenovirus vectors with increased affinity to CD46","volume":"82","author":"Roffler","year":"2008","journal-title":"J Virol"},{"key":"47","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1038\/ncomms8396","article-title":"Site-specific processing of Ras and Rap1 Switch I by a MARTX toxin effector domain","volume":"6","author":"Satchell","year":"2015","journal-title":"Nat Commun"},{"key":"48","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI117747","article-title":"The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile","volume":"95","author":"Aktories","year":"1995","journal-title":"J Clin Invest"},{"key":"49","doi-asserted-by":"crossref","first-page":"41252","DOI":"10.1038\/srep41252","article-title":"Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells","volume":"7","author":"Schmidt","year":"2017","journal-title":"Sci Rep"},{"key":"50","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nsmb.2688","article-title":"A bacterial toxin catalyzing tyrosine glycosylation of Rho and deamidation of Gq and Gi proteins","volume":"20","author":"Aktories","year":"2013","journal-title":"Nat Struct Mol Biol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:22:56Z","timestamp":1589037776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":50,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,3,27]]}},"alternative-id":["24740","29662661"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24740","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]}}}